Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis.
Spontaneous intramedullary apoptosis was measured in bone marrow (BM) biopsies of 175 patients with myelodysplastic syndromes (MDS) using in situ end-labeling (ISEL) of fragmented DNA. Two groups of high (n=71) versus low (n =43) levels of apoptosis were identified while 61 patients were ISEL-negative. Semiquantitative assessment of 3 cytokines, the number of macrophages and in vivo labeling indices (LI) were also determined from consecutive sections of the biopsy. Patients with high apoptosis levels tended to have a high LI (p=0.013), more macrophages in their BM biopsies (p=0.006) and higher tumor necrosis factor alpha (TNF-alpha) levels (not significant) compared to patients with no apoptosis. In addition, low risk MDS patients had significantly lower rates of apoptosis (p = 0.047) and lower levels of TNF-alpha (p = 0.055) compared to high-risk MDS patients. We conclude that the genesis of cytopenias in MDS is of multifactorial origin and that cytokine-associated apoptosis clearly identifies a distinct biological subgroup of patients who may benefit selectively by use of anti-cytokine therapies.
Dar
S
S
Rush Cancer Institute, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612-3515, USA.
Mundle
S
S
Andric
T
T
Qawi
H
H
Shetty
V
V
Reza
S
S
Mativi
B Y
BY
Allampallam
K
K
Ali
A
A
Venugopal
P
P
Gezer
S
S
Broady-Robinson
L
L
Cartlidge
J
J
Showel
M
M
Hussaini
S
S
Ragasa
D
D
Ali
I
I
Chaudhry
A
A
Waggoner
S
S
Lisak
L
L
Huang
R W
RW
Raza
A
A
D000368:Aged; D017209:Apoptosis; D015415:Biomarkers; D001853:Bone Marrow / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000473:pathology* / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D015415:Biomarkers; D014409:Tumor Necrosis Factor-alpha